Becton, Dickinson and Company

Add to watchlist
$241.44
Last updated:06/15/2021
BDX: NYSE
Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis cat… Show more

Dividend yield
1.36%
$3.28 anually

3y growth is 2.94%– Yield is 40% lower than average in Health Care sector

P/E ratio
43.02x
vs. 18.87x forward

Price is 43.02x times more than EPS $5.61 which eaquals $241.44

Payout ratio
58.45%
Yearly

58.45% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
BDX dividends
Payout frequency
Quarterly
Latest ex-date
06/08/2021
3y growth
2.94%
5y growth
3.93%
$0.75
$0.75
03/08/2018
$0.75
$0.75
06/07/2018
$0.75
$0.75
09/06/2018
$0.77
$0.77
12/07/2018
2018
$3.02
$0.77
$0.77
03/07/2019
$0.77
$0.77
06/06/2019
$0.77
$0.77
09/06/2019
$0.79
$0.79
12/09/2019
2019
$3.1
$0.79
$0.79
03/09/2020
$0.79
$0.79
06/08/2020
$0.79
$0.79
09/08/2020
$0.83
$0.83
12/09/2020
2020
$3.2
$0.83
$0.83
03/09/2021
$0.83
$0.83
06/08/2021
2021
So far
$1.66
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
1.1B
311M
-71.73%
1.233B
+296.46%
874M
-29.12%
Cashflow
Sum up money going in and out company
2.55B
2.865B
+12.35%
3.33B
+16.23%
3.539B
+6.28%
Total liabilities
All combined debts and obligations
24.786B
32.91B
+32.78%
30.684B
-6.76%
30.248B
-1.42%
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 7 ETFs that include this stock
Company profile
CEO
Mr. Thomas E. Polen Jr.
Market capitalization
Mega (70.59B)
BDX price history
Loading price stock history...